The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
The tumor suppressor miR-138-5p targets PD-L1 in colorectal cancer.
复制标题
结直肠癌中肿瘤抑制因子 miR-138-5p 靶向 PD-L1
DOI:
10.18632/oncotarget.9659
复制
发表时间:
2016-07-19
期刊:
影响因子:
--
通讯作者:
Shen S
中科院分区:
文献类型:
--
作者:
Zhao L;Yu H;Yi S;Peng X;Su P;Xiao Z;Liu R;Tang A;Li X;Liu F;Shen S
microRNAs (miRNAs) play critical roles in cancer development and progression. This study investigated the effects of miR-138-5p in human colorectal cancer (CRC) development. miR-138-5p was frequently downregulated in CRC tissues and was associated with advanced clinical stage, lymph node metastasis and poor overall survival. We found that miR-138-5p decreased expression of programmed cell death ligand 1 (PD-L1) through interaction with its PD-L1 3′ untranslated region. miR-138-5p also dramatically suppressed CRC cell growth in vitro and inhibited tumorigenesis in vivo. PD-L1 and miR-138-5p levels were inversely correlated in human CRC tumors, and miR-138-5p inhibited PD-L1 expression in tumor models. These results suggest that miR-138-5p is a tumor suppressor in CRC, and its effects are exerted at least partially through PD-L1 downregulation. Low miR-138-5p and high PD-L1 levels correlated with shorter overall CRC patient survival, indicating that miR-138-5p and PD-L1 may serve as CRC biomarkers for risk group assignment, optimal therapy selection and clinical outcome prediction. Targeting PD-L1, possibly by administering miR-138-5p mimics, might be a clinically effective anti-CRC therapeutic strategy.
登录
查看更多内容
影响因子:
7.2
作者:
Peng W;Lizée G;Hwu P
通讯作者:
Hwu P
影响因子:
--
作者:
Darb-Esfahani S;Kunze CA;Kulbe H;Sehouli J;Wienert S;Lindner J;Budczies J;Bockmayr M;Dietel M;Denkert C;Braicu I;Jöhrens K
通讯作者:
Jöhrens K
影响因子:
8.4
作者:
Droeser, Raoul A.;Hirt, Christian;Tornillo, Luigi
通讯作者:
Tornillo, Luigi
影响因子:
11.5
作者:
Konishi, J;Yamazaki, K;Nishimura, M
通讯作者:
Nishimura, M
影响因子:
11.5
作者:
Ohigashi, Y;Sho, M;Nakajima, Y
通讯作者:
Nakajima, Y